background
polymeras
chain
reaction
pcr
sensit
tool
detect
respiratori
picornavirus
howev
clinic
relev
picornaviru
detect
pcr
unclear
immunofluoresc
wide
use
detect
respiratori
virus
recent
introduc
promis
detect
method
respiratori
picornavirus
object
compar
clinic
manifest
respiratori
picornaviru
infect
detect
respiratori
picornaviru
infect
detect
xtag
multiplex
pcr
hospit
children
studi
design
period
nasopharyng
aspir
npa
children
hospit
due
acut
respiratori
infect
prospect
analyz
respiratori
picornaviru
posit
sampl
neg
sampl
test
xtag
multiplex
pcr
exclus
children
comorbid
viral
coinfect
monoinfect
respiratori
picornavirus
detect
npa
otherwis
healthi
children
andor
pcr
compar
group
children
pcr
posit
n
group
children
neg
pcr
posit
n
regard
clinic
manifest
infect
result
wheezi
bronchiti
diagnos
often
group
group
vs
p
contrast
group
patient
diagnos
frequent
pneumonia
vs
p
accompani
higher
level
creactiv
protein
mgl
vs
mgl
p
conclus
picornaviru
detect
children
acut
respiratori
infect
associ
clinic
present
wheezi
bronchiti
find
frequent
diagnosi
pneumonia
picornaviru
pcr
posit
neg
children
warrant
investig
background
polymeras
chain
reaction
pcr
sensit
tool
detect
respiratori
picornavirus
howev
clinic
relev
picornaviru
detect
pcr
unclear
immunofluoresc
wide
use
detect
respiratori
virus
recent
introduc
promis
detect
method
respiratori
picornavirus
object
compar
clinic
manifest
respiratori
picornaviru
infect
detect
respiratori
picornaviru
infect
detect
xtag
multiplex
pcr
hospit
children
studi
design
period
nasopharyng
aspir
npa
children
hospit
due
acut
respiratori
infect
prospect
analyz
respiratori
picornaviru
posit
sampl
neg
sampl
test
xtag
multiplex
pcr
exclus
children
comorbid
viral
coinfect
monoinfect
respiratori
picornavirus
detect
npa
otherwis
healthi
children
andor
pcr
compar
group
children
pcr
posit
n
group
children
neg
pcr
posit
n
regard
clinic
manifest
infect
result
wheezi
bronchiti
diagnos
often
group
group
vs
p
contrast
group
patient
diagnos
frequent
pneumonia
vs
p
accompani
higher
level
creactiv
protein
mgl
vs
mgl
p
conclus
picornaviru
detect
children
acut
respiratori
infect
associ
clinic
present
wheezi
bronchiti
find
frequent
diagnosi
pneumonia
picornaviru
pcr
posit
neg
children
warrant
investig
elsevi
bv
right
reserv
respiratori
picornavirus
enterovirus
rhinovirus
common
etiolog
agent
upper
lower
respiratori
tract
infect
pediatr
patient
picornavirus
found
children
acut
respiratori
symptom
almost
children
experienc
rhinoviru
infect
age
year
moreov
rhinovirus
associ
five
hospit
per
children
year
age
indic
substanti
morbid
age
group
rapid
detect
respiratori
picornavirus
import
avoid
nosocomi
transmiss
children
reduc
unnecessari
antibiot
use
decreas
hospit
stay
consequ
enhanc
costeffect
medic
manag
current
method
use
detect
respiratori
picornavirus
nucleic
acid
amplif
eg
polymeras
chain
reaction
pcr
howev
method
expens
timeconsum
allow
rapid
diagnosi
recent
shown
detect
respiratori
picornavirus
immunofluoresc
children
feasibl
routin
diagnost
procedur
may
advantag
molecular
method
although
pcr
sensit
detect
respiratori
picornavirus
compar
remain
unknown
whether
addit
detect
respiratori
picornavirus
alway
clinic
relev
address
question
retrospect
analyz
clinic
data
children
hospit
picornaviru
infect
see
front
matter
elsevi
bv
right
reserv
tabl
comparison
clinic
featur
group
pcr
posit
group
neg
pcr
posit
children
respiratori
picornaviru
monoinfect
nasopharyng
aspir
npa
collect
children
year
age
admit
emerg
room
univers
children
hospit
bern
switzerland
subsequ
hospit
due
acut
respiratori
tract
infect
novemb
octob
specimen
prospect
test
respiratori
picornavirus
enteroviru
rhinoviru
adenoviru
adv
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
influenzaviru
ifa
influenzaviru
b
ifb
human
metapneumoviru
hmpv
studi
picornaviru
posit
sampl
neg
npa
sampl
test
xtag
respiratori
viral
panel
multiplex
rtpcr
includ
respiratori
picornavirus
adv
rsv
piv
ifa
ifb
hmpv
coronavirus
recent
describ
provid
frozen
materi
left
children
viral
coinfect
n
comorbid
n
exclud
result
homogen
group
otherwis
healthi
children
mean
age
month
rang
month
femal
respiratori
picornaviru
monoinfect
children
evalu
blind
chart
audit
clinic
data
later
classifi
group
pcr
posit
group
neg
pcr
posit
blood
cultur
routin
taken
npa
sampl
process
stain
formerli
describ
light
diagnost
chemicon
intern
millipor
temecula
ca
respiratori
viral
screen
dfa
singl
fluoresceinconjug
monoclon
antibodi
diagnost
hybrid
dfa
metapneumoviru
identif
kit
use
detect
adv
rsv
piv
ifa
ifb
hmpv
respect
accord
manufactur
instruct
detect
respiratori
picornavirus
specimen
test
light
diagnost
panenteroviru
reagent
blend
rna
dna
extract
easymag
extractor
use
gener
protocol
xtag
respiratori
viral
panel
assay
carri
accord
manufactur
instruct
detect
amplicon
done
luminex
instrument
detail
descript
method
see
merant
et
al
raw
data
output
file
consist
median
fluoresc
intens
virus
subtyp
interpret
use
tda
rvpi
softwar
luminex
molecular
diagnost
statist
analysi
carri
use
graph
pad
prism
softwar
tool
eightyfour
patient
xtag
multiplex
pcr
posit
group
patient
neg
xtag
multiplex
pcr
posit
group
shown
tabl
signific
differ
group
regard
age
length
hospit
stay
length
oxygen
requir
group
patient
show
significantli
often
wheez
often
retract
compar
group
patient
although
latter
differ
reach
statist
signific
contrast
group
patient
significantli
often
febril
show
significantli
higher
median
crp
count
trend
group
patient
toward
higher
white
blood
cell
level
frequent
use
antibiot
therapi
shown
tabl
wheezi
bronchiti
often
diagnos
group
compar
group
contrast
group
patient
significantli
frequent
diagnos
pneumonia
studi
investig
differ
clinic
manifest
respiratori
picornaviru
infect
detect
xtag
multiplex
pcr
respiratori
picornaviru
infect
detect
xtag
multiplex
pcr
hospit
children
group
children
pcr
posit
develop
wheezi
bronchiti
significantli
often
compar
group
children
neg
pcr
posit
howev
group
children
diagnos
significantli
often
pneumonia
accompani
higher
bodi
temperatur
higher
level
creactiv
protein
previous
shown
rapid
inexpens
method
detect
respiratori
picornavirus
show
detect
respiratori
picornavirus
correl
well
clinic
find
wheez
ill
frequent
manifest
respiratori
picornaviru
infect
children
hospit
set
unexpect
find
frequent
diagnosi
pneumonia
children
neg
picornaviru
detect
posit
detect
pcr
need
address
viral
pneumonia
children
associ
rhinovirus
howev
role
etiolog
lower
tract
infect
subject
debat
presenc
respiratori
picornaviru
rna
necessarili
prove
causeeffect
relationship
combin
viralbacteri
infect
possibl
studi
higher
creactiv
protein
level
children
picornaviru
posit
pcr
suggest
symptom
may
caus
secondari
bacteri
superinfect
highli
sensit
xtag
multiplex
pcr
detect
also
past
symptomat
asymptomat
viral
infect
shown
enteroviru
rhinoviru
rna
persist
sever
week
onset
symptomat
respiratori
infect
detect
substanti
proport
children
without
respiratori
symptom
thu
rel
insensit
might
benefit
clinic
practic
clinic
data
analyz
retrospect
collect
blood
cultur
routin
provid
data
support
hypothesi
possibl
bacteri
superinfect
children
predisposit
bacteri
infect
viral
infect
wellknown
evalu
clinic
cours
respiratori
picornaviru
monoinfect
healthi
children
exclud
children
coinfect
comorbid
found
picornaviru
infect
associ
substanti
clinic
econom
impact
shown
median
hospit
stay
day
median
oxygen
requir
day
impli
need
fast
inexpens
detect
method
virus
conclud
studi
popul
appear
rapid
inexpens
reliabl
detect
method
respiratori
picornaviru
correl
well
clinic
present
wheezi
bronchiti
therefor
recommend
clinic
applic
detect
respiratori
picornaviru
rna
npa
children
acut
respiratori
infect
molecular
method
expens
may
perhap
result
discoveri
noncaus
remnant
prior
symptomat
asymptomat
infect
